在新选项卡中打开链接
  1. Forbes
    https://www.forbes.com › sites › ariannajohnson › what-we-know-about-the-male...

    What We Know About The Male Birth Control Pill YCT-529 Tested …

    • Therapeutics began its phase I trial of its daily male birth control pill known as YCT-529 this week, which involves British participants. Unlike the female birth control pill, YCT-529 is a hormone-free type of retinoi… 展开

    Big Number

    $200 billion. That’s how much the market value of new male contraceptives is worth (between $40 … 展开

    Forbes
    Crucial Quote

    “The world is ready for a male contraceptive agent and delivering one that’s hormone-free is simply the right thing to do given what we know about the side effects women h… 展开

    Forbes
    Key Background

    Though almost half of all pregnancies worldwide are unintended, the only contraceptive options available to men are condoms and vasectomies, according to the National Insti… 展开

    Forbes
    Tangent

    There are several types of female birth control options, including pills, patches, intrauterine devices (IUD) and rings, which range from 71% efficacy to 99% efficacy. Though they hav… 展开

    Forbes
    YourChoice Therapeutics Begins First-In-Human Trial for Male Birt…
    YourChoice Therapeutics is a biopharmaceutical company developing YCT-529, a drug candidate that blocks vitamin A signaling in the testes to prevent sperm production. The company has started a phase one clinical study in men to test the safety, effectiveness, and reversibility of YCT-529 as a hormone-free male birth control pill.
    Pharmacy · https://www.pharmacy.umn.edu/ne…
    反馈
    目录
    Big Number
    Crucial Quote
    Key Background
    Tangent